WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3301 Infant (under 12 months) mortality rate: 912
GDP / capita (US$): 6061 Child (under 5 years) mortality rate: 1292

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 4'709  4'616  4'525  4'436  4'350  3'638  2'913  2'274 
Births 160  158  156  155  153  143  120  97 
Surviving infants 145  143  142  140  138  127  106  86 
Pop. less than 5 years 685  674  662  653  646  591  496  385 
Pop. less than 15 years 1'861  1'839  1'815  1'791  1'768  1'539  1'261  961 
Female 15-49 years 1'176  1'145  1'116  1'088  1'060  856  660  519 

Number of reported case

(Click for retrospective incidence data for Central African Republic (the))
Diphtheria 35 
Japanese encephalitis
Measles 210  596  141  679  3'207  1'275  8'280 
Mumps
Pertussis 241  124  124  100  46  4'340 
Polio* 28  21 
Rubella 507  31  11  15  15 
Rubella (CRS)
Tetanus (neonatal) 24  68  65  49  20  37  32 
Tetanus (total)** 24  68  74  49  20  37  34  217 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Central African Republic (the))
Vaccine year result method % card seen                                                
BCG 2011  74  EPI   50  50  39  61  69  64  47  93  17 
DTP1 2009  65  MICS   32  72  44  78  84  71  46 
DTP3 2011  47  EPI   50  45  28  59  64  58  29  61  13 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  47  EPI   50  45  28  58  64  58 
Hib3 2011  47  EPI   50  45  28  58  64  58 
JapEnc         
MCV1          59  29  65  80  62  34  67  12 
MCV2         
PCV1          63  32  75  38 
PCV3          38  20  52 
Pol3 2011  71  EPI   50  50  28  55  67  58  31  57  13 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  53  MICS   32  53  33  76  81  50  20  65 
PAB         
VAD1          40  13  19 
YFV 2011  48  EPI   50  44  29  64  79  64  19 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Central African Republic (the))
BCG 74  37  74  74  74  66  96  17 
DTP1 69  35  69  69  67  60  95  35 
DTP3 47  23  47  47  45  37  82  13 
HepB3 47  23  47  47  45 
HepB_BD
Hib3 47  23  47  47  45 
MCV1 49  25  49  49  53  36  82  12 
MCV2
PAB 60  66  66  80  86  36  69 
PCV3 47  23  47 
Pol3 47  23  47  47  46  38  82  13 
Rota_last
YFV 48  24  48  48  55  36 

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
74 
   
/
|
|
\
Greater or equal to 90% 7
From 80 to 89% 3
From 50 to 79% 37
Less than 50% 53
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From September 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks Yes From June 2016
Td 1st contact; +1, +6 months; +1, +1 years Yes Pregnant women
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2008 - 2012  2008-2012  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 22  24  24  24  24  24  24 

System performance

Total Nº districts in country number 30  24  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 10  13  33  13  38 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 20  38  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  Yes  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 18  1'783  66 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No    No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.